The global Bovine Mastitis Market is estimated to be valued at US$ 1497.52 Mn in 2023 and is expected to exhibit a CAGR of 9.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Bovine mastitis is an infection of the udder that affects dairy cattle. Mastitis impacts milk production and quality and increases treatment costs for dairy farmers. The condition is caused by various pathogenic microorganisms such as bacteria, yeast, and fungi. Treatment involves antibiotics and other anti-inflammatory drugs that target udder infections. The growing prevalence of mastitis among dairy herds globally isdriving demand for diagnostic tests, antibiotics, and other treatment products in the bovine mastitis market.
Market key trends:
The increasing prevalence of mastitis in dairy cattle is one of the key drivers propelling growth of the global bovine mastitis market. Mastitis accounts for huge economic losses to the dairy industry each year due to discarded milk, treatment costs, and reduced milk production. According to data from the National Mastitis Council, clinical mastitis occurrence averages 18-32% on dairy farms in various regions worldwide. Subclinical mastitis has a prevalence of 30-50% among dairy herds globally. The high and growing incidence of this disease among dairy cattle is increasing the need for rapid and reliable diagnostic testing as well as effective treatment and control, thereby fueling demand for products in the bovine mastitis market.
Strength: Bovine mastitis negatively impacts milk production in dairy cows. Timely diagnosis and treatment can help improve cow health and welfare.
Weakness: Diagnosis of subclinical mastitis can be challenging as there are no visible signs of infection. Early detection requires regular milk screening which increases costs.
Opportunity: Advances in diagnostic technologies like PCR tests and rapid on-farm screening kits allow for faster and more accurate identification of mastitis-causing pathogens. This aids prompt treatment decisions.
Threats: Emergence of antibiotic-resistant bacteria makes treatment of mastitis infections more difficult. Strict regulations on antimicrobial use in dairy farms also limit treatment options.
Global Bovine Mastitis Market Size is expected to witness high growth over the forecast period of 2023 to 2030.
Regional Analysis: The region of North America currently dominates the market and is expected to continue its dominance during this period. Factors such as the rising dairy production in countries like the US and Canada as well as greater awareness among farmers regarding bovine mastitis diagnostics and therapeutics drive the growth of this region.
Key players operating in the bovine mastitis market are GE Healthcare, Siemens Healthineers, Philips Healthcare, Cardinal Health, Lantheus Medical Imaging, Bayer AG, Bracco Imaging, EczacÄ±baÅŸÄ±-Monrol Nuclear Products, Nordion, Advanced Accelerator Applications, NTP Radioisotopes, Curium Pharma, Jubilant Life Sciences Ltd, IRE â€“ IRE ELiT â€“ Instituto de Pesquisas EnergÃ©ticas e Nucleares, Australian Nuclear Science and Technology Organisation (ANSTO), Eckert & Ziegler Radiopharma GmbH, Isotopia Molecular Imaging Ltd., Institute of Atomic Energy of Bangladesh, Rosatom State Atomic Energy Corporation, Board of Radiation and Isotope Technology (BRIT). These companies offer a variety of diagnostic kits, antibiotics, anti-inflammatory drugs, and other treatment products targeting subclinical and clinical mastitis in dairy cows.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it